Metabolic syndrome and breast cancer in the Me-Can (metabolic syndrome and cancer) project

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 7, 2010, Pages 1737-1745

  Bjørge, Tone ^a,b   Lukanova, Annekatrin ^c   Jonsson, Håkan ^d   Tretli, Steinar ^e   Ulmer, Hanno ^f   Manjer, Jonas ^g   Stocks, Tanja ^d   Selmer, Randi ^b   Nagel, Gabriele ^h   Almquist, Martin ^g   Concin, Hans ⁱ   Hallmans, Göran ^d   Häggström, Christel ^d   Stattin, Pär ^d   Engeland, Anders ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UMEÅ UNIVERSITY   (Sweden)

^e CANCER REGISTRY OF NORWAY   (Norway)

^f INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^g LUND UNIVERSITY HOSPITAL   (Sweden)

^h UNIVERSITY OF ULM   (Germany)

ⁱ AGENCY FOR PREVENTIVE AND SOCIAL MEDICINE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL;

ADULT; ARTICLE; AUSTRIA; BODY HEIGHT; BODY MASS; BODY POSITION; BODY WEIGHT; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NORWAY; POSTMENOPAUSE; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; STANDARDIZATION; SWEDEN; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; AGE; AGED; BREAST NEOPLASMS; COHORT ANALYSIS; COMPLICATION; INCIDENCE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK;

ADULT; AGE FACTORS; AGED; AUSTRIA; BODY MASS INDEX; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; METABOLIC SYNDROME X; MIDDLE AGED; NORWAY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; RISK FACTORS; SWEDEN;

EID: 77954528680     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0230     Document Type: Article

References (40)

1. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research; 2007.
2. Xue F, Michels KB. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 2007;86:s823-35.
3. Furberg AS, Veierød MB, Wilsgaard T, Bernstein L, Thune I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 2004;96:1152-60. (Pubitemid 39207051)
4. Muti P, Quattrin T, Grant BJ, et al. Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2002;11:1361-8.
5. Soler M, Chatenoud L, Negri E, Parazzini F, Franceschi S, la Vecchia C. Hypertension and hormone-related neoplasms in women. Hypertension 1999;34:320-5.
6. Agnoli C, Berrino F, Abagnato CA, et al. Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Nutr Metab Cardiovasc Dis 2010;20:41-8.
7. Kabat GC, Kim M, Chlebowski RT, et al. A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2009;18:2046-53.
8. Russo A, Autelitano M, Bisanti L. Metabolic syndrome and cancer risk. Eur J Cancer 2008;44:293-7.
9. Clavel-Chapelon F. Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women. Br J Cancer 2002;86:723-7.
10. Pasanisi P, Berrino F, De Petris M, Venturelli E, Mastroianni A, Panico S. Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer 2006;119:236-8.
11. Stocks T, Borena W, Strohmaier S, et al. Cohort profile: the metabolic syndrome and cancer project (Me-Can). Int J Epidemiol 2010;39:660-7.
12. Bjørge T, Stocks T, Lukanova A, et al. Metabolic syndrome and endometrial carcinoma. Am J Epidemiol 2010;171:892-902.
13. Eurostat, European shortlist for causes of death, 1998. http://ec.europa.eu/eurostat/ramon/nomenclatures/index.cfm?TargetUrl= LST-NOM-DTL&StrNom=COD-1998. 2009
14. Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall Ltd; 1984.
15. Wood AM, White I, Thompson SG, Lewington S, Danesh J. Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies. Int J Epidemiol 2006;35:1570-8.
16. Fibrinogen Studies Collaboration. Correcting for multivariate measurement error by regression calibration in meta-analyses of epidemiological studies. Stat Med 2009;28:1067-92.
17. Clarke R, Shipley M, Lewington S, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 1999;150:341-53. (Pubitemid 29383482)
18. Emberson JR, Whincup PH, Morris RW, Walker M, Lowe GD, Rumley A. Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study. Eur J Cardiovasc Prev Rehabil 2004;11:125-34.
19. Whitlock G, Clark T, Vander HS, et al. Random errors in the measurement of 10 cardiovascular risk factors. Eur J Epidemiol 2001;17:907-9.
20. Stocks T, Rapp K, Bjørge T, et al. Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (Me-Can). PLoS Med 2009;6:e1000201.
21. Larsen IK, Smastuen M, Johannesen TB, et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009;45:1218-31.
22. Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 2009;48:27-33.
23. Rapp K, Schroeder J, Klenk J, et al. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 2006;49:945-52.
24. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
25. Kahn R. Metabolic syndrome-what is the clinical usefulness? Lancet 2008;371:1892-3.
26. Stocks T, Lukanova A, Johansson M, et al. Components of the metabolic syndrome and colorectal cancer risk; a prospective study. Int J Obes (Lond) 2008;32:304-14.
27. Unwin N. The metabolic syndrome. J R Soc Med 2006;99:457-62.
28. Suzuki R, Orsini N, Saji S, Key TJ, Wolk A. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status - a meta-analysis. Int J Cancer 2009;124:698-712.
29. Cust AE, Stocks T, Lukanova A, et al. The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study. Breast Cancer Res Treat 2009;113:567-76.
30. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-91. (Pubitemid 39025053)
31. Rose DP, Haffner SM, Baillargeon J. Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. Endocr Rev 2007;28:763-77.
32. van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000;152:514-27.
33. Stephenson GD, Rose DP. Breast cancer and obesity: an update. Nutr Cancer 2003;45:1-16.
34. Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B. Diabetes mellitus and breast cancer. Lancet Oncol 2005;6:103-11.
35. Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, Goodwin PJ. Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 1998;47:111-20.
36. Strasak AM, Pfeiffer RM, Brant LJ, et al. Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172 210 men and women: a prospective 19-year follow-up study. Ann Oncol 2009;20:1113-20.
37. Jacobs EJ, Gapstur SM. Cholesterol and cancer: answers and new questions. Cancer Epidemiol Biomarkers Prev 2009;18:2805-6.
38. Peeters PH, van Noord PA, Hoes AW, Fracheboud J, Gimbrere CH, Grobbee DE. Hypertension and breast cancer risk in a 19-year follow-up study (the DOM cohort). Diagnostic investigation into mammarian cancer. J Hypertens 2000;18:249-54.
39. Emaus A, Veierød MB, Tretli S, et al. Metabolic profile, physical activity, and mortality in breast cancer patients. Breast Cancer Res Treat 2010;121:651-60.
40. Maruthur NM, Bolen S, Brancati FL, Clark JM. Obesity and mammography: a systematic review and meta-analysis. J Gen Intern Med 2009;24:665-77.